In this episode of the Interventional Glaucoma Podcast, Prof. Verena Prokosch and Ms. Nishani Amerasinghe discuss the integration of minimally invasive glaucoma surgery (MIGS) into routine cataract surgery. They focus on how laser-based trabecular procedures can be efficiently combined with phacoemulsification to improve outcomes for glaucoma patients.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices.  Find out more about ELIOS : http://bit.ly/4lWBJZ1

In this episode, host Gok Ratnarajan is joined by Dr. Ana Miguel, Dr. Karl Mercieca, and Dr. Jose Belda to explore whether patients truly experience greater happiness following glaucoma surgery. Through anonymized case studies and real-world examples, the panel delves into how an interventional glaucoma approach can impact patient quality of life. Together, they reflect on patient expectations and outcomes, sharing personal experiences to provide a balanced and insightful discussion on the patient perspective in glaucoma care.   The ELIOS system (Bausch & Lomb) is manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17, Germany and by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked for use in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). The ExTra II (laser class 4) has the brand name ELIOS. The ExTra II is equivalent to ExTra and AIDA devices. 

In this episode, Professor Ike Ahmed welcomes Dr. Ticiana de Francesco, Dr. Nathan Radcliffe, and Dr. Mark Gallardo to discuss goal setting in interventional glaucoma care. They emphasize the importance of aligning treatment strategies with patient expectations, focusing on disease control while aiming to reduce or eliminate medication use.  They introduce a practical tool to support goal setting, which can be downloaded at https://eliosvision.com/ous/resources/.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

In this second episode of a special two-part series on the Interventional Glaucoma Podcast, host Gok Ratnarajan is joined by Anselm Juenemann, Dan Lindfield, Jose Belda, and Nils Loewen to share insights from their first 100 ELIOS cases. They discuss patient selection, technique, and post-op management, while also exploring strategies to reduce the learning curve.  The conversation covers the safety and efficacy of ELIOS, and how to manage medications post-op for the best outcomes. The experts highlight the importance of clinical experience in achieving reliable results and provide valuable tips for glaucoma surgeons.  

In this first episode of the special two-episode series of the Interventional Glaucoma podcast, host Gok Ratnarajan is joined by esteemed guests Anselm Juenemann, Dan Lindfield, Jose Belda, and Nils Loewen to discuss key insights from their first 100 Elios cases. They share expert tips on technique, patient selection, and post-op management while exploring strategies to reduce the Elios learning curve. The conversation also delves into the safety and efficacy of the procedure and its impact on patient quality of life.

In this episode of the Interventional Glaucoma podcast, Prof. Ike Ahmed presents a series of ELIOS case studies recorded by Dr. Ana Miguel, Dr. Jose Belda, Dr. Karl Mercieca, and Ms. Nishani Amerasinghe. The cases explore the versatility of the ELIOS procedure in managing glaucoma, from early intervention in ocular hypertension to addressing complex cases with prior MIGS treatments.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

In this episode of the Interventional Glaucoma podcast, professor Gus Gazzard is joined by Ms. Nishani Amerasinghe and Dr Jose Belda to discuss the concept of routine Phaco Plus. They explore the benefits, safety, and patient outcomes associated with Phaco Plus, as well as its current adoption across Europe.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

In this episode of the Interventional Glaucoma podcast, Dr. Karl Mercieca, Dr. Gok Ratnarajan, and Dr. Ana Miguel discuss the future of glaucoma management, emphasising the potential of minimally invasive glaucoma surgery (MIGS) to improve patients' quality of life and treatment outcomes.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

En este episodio del podcast sobre glaucoma intervencionista, los prestigiosos cirujanos españoles el Dr. José Belda, la Dra. María Isabel Canut y la Dra. Marta Ibarz se reúnen para comentar las razones que justifican la combinación rutinaria de la MIGS con la cirugía de cataratas y los beneficios que ofrece a los pacientes.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

In this episode of the Interventional Glaucoma podcast, Professor Gus Gazzard welcomes Professor Christophe Baudouin, Mr Gok Ratnarajan and Dr Ana Miguel to discuss the impact of glaucoma treatments on patients' quality of life, emphasising the benefits of minimally invasive glaucoma surgeries (MIGS) in reducing reliance on eye drops and improving overall patient well-being.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

In this episode of the Interventional Glaucoma podcast, Dr. Cathy McCabe, Dr. Mark Gallardo and Mr. Dan Lindfield delve into the post-operative care and expectations following the Elios procedure, highlighting the similarities to routine cataract surgery and long-term outcomes in IOP and medication reduction.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

In this episode of the Interventional Glaucoma podcast, Dr. Cathy McCabe hosts a discussion with Dr. Mark Gallardo and Mr. Dan Lindfield about intra-operative pearls for the Elios procedure. They delve into the nuances of patient positioning, visualization techniques and probe handling, offering practical insights and tips for surgeons considering adopting this innovative technology.     Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

In this episode of the Interventional Glaucoma podcast, host Dr. Cathy McCabe is joined by Dr. Mark Gallardo and Mr. Dan Lindfield to explore Elios, a minimally invasive and precise solution for patients with cataracts and glaucoma. The conversation delves into patient selection criteria, effective communication strategies, and the need for a shift towards holistic patient-centered care.   Elios Vision GmbH is the EU distributor of ELIOS manufactured by MLase GmbH, located at 82110 Germering, Industriestr. 17 Germany, and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH, Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. ELIOS is CE marked and licensed for use in the EU in adult patients with glaucoma and is currently under investigational use in the US as part of an ongoing IDE study (FDA). Product feedback should be sent to productsurveillance@eliosvision.com.

If the basic concept that impairment in aqueous humor outflow results in elevation of the IOP is a central tenet of glaucoma pathology and treatment; what three facts should all ophthalmologists know about aqueous humor dynamics?  Dr. Ike Ahmed and Professor Gus Gazzard sit down with Professor Carl Sheridan to answer this question. They highlight the clinical implications of understanding these dynamics while emphasizing the importance of early intervention and tissue preservation.

Dr. Ike Ahmed and Professor Gus Gazzard are joined by Professor Carl Sheridan to discuss the complexities of the trabecular meshwork and its significance in glaucoma management. They deconstruct some common myths and misconceptions surrounding the structure, and explore the importance of early intervention and precision treatments in obtaining maximum preservation.

Professor Gus Gazzard is joined by Ahmad Elsahn to delve into the use of excimer laser technology and its impact in shifting mindsets towards more interventional strategies for glaucoma patients. They provide insights into the distinct characteristics of the excimer laser, and discuss the safety and efficacy of the treatment.

Dr. Ike Ahmed and Professor Gus Gazzard kick off the Interventional Glaucoma podcast series with an unscripted discussion about the evolving mindset of interventional glaucoma.  They explore the motivations behind this shift, including the need to address the limitations of current treatments, and highlight cataract surgery as an opportune entry point to intervene with simultaneous glaucoma treatment.